45Therefore, the Member States may choose to apply a reduced rate of VAT to specific pharmaceutical products or medical devices among those mentioned in points (3) and (4) of Annex III to that directive, while applying the standard rate to other such products or devices (see, to that effect, judgment of 9 March 2017, Oxycure Belgium, C‑573/15, EU:C:2017:189, paragraph 26).
Source: EUR-Lex, © European Union, 1998-2026. Reuse authorised under Decision 2011/833/EU.